Ovid Therapeutics to Present at Upcoming August Investor Conferences
Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company focused on improving lives affected by epilepsies and brain conditions, has announced its participation in two upcoming investor conferences in August 2024:
1. BTIG Virtual Biotechnology Conference: Ovid will engage in a fireside chat on Tuesday, August 6th at 10:00 a.m. ET.
2. 2024 Wedbush PacGrow Healthcare Conference: The company will participate in a panel discussion on Tuesday, August 13th at 10:15 a.m. ET.
Both events will be accessible via live webcasts through the Events & Presentations section of Ovid's website at investors.ovidrx.com. Archived replays will be available on the company's website following the live presentations.
Ovid Therapeutics Inc. (NASDAQ: OVID), un'azienda biofarmaceutica focalizzata sul miglioramento delle vite delle persone affette da epilessie e condizioni cerebrali, ha annunciato la sua partecipazione a due prossime conferenze per investitori nell'agosto 2024:
1. Conferenza Virtuale di Biotecnologia BTIG: Ovid parteciperà a una chiacchierata informale martedì 6 agosto alle 10:00 ET.
2. Conferenza Wedbush PacGrow Healthcare 2024: L'azienda parteciperà a una discussione di panel martedì 13 agosto alle 10:15 ET.
Entrambi gli eventi saranno accessibili tramite webcast dal vivo nella sezione Eventi & Presentazioni del sito web di Ovid su investors.ovidrx.com. Le registrazioni archiviate saranno disponibili sul sito dell'azienda dopo le presentazioni dal vivo.
Ovid Therapeutics Inc. (NASDAQ: OVID), una compañía biofarmacéutica enfocada en mejorar las vidas de quienes padecen epilepsias y condiciones cerebrales, ha anunciado su participación en dos próximas conferencias de inversores en agosto de 2024:
1. Conferencia Virtual de Biotecnología de BTIG: Ovid participará en una charla informal el martes 6 de agosto a las 10:00 a.m. ET.
2. Conferencia de Salud Wedbush PacGrow 2024: La compañía participará en una discusión de panel el martes 13 de agosto a las 10:15 a.m. ET.
Ambos eventos serán accesibles a través de webcast en vivo en la sección de Eventos y Presentaciones del sitio web de Ovid en investors.ovidrx.com. Las repeticiones archivadas estarán disponibles en el sitio de la compañía tras las presentaciones en vivo.
Ovid Therapeutics Inc. (NASDAQ: OVID)는 간질 및 뇌 질환으로 영향을 받는 사람들의 삶을 개선하는 데 중점을 둔 바이오 제약 회사로, 2024년 8월에 있을 두 개의 투자자 회의에 참여할 것이라고 발표했습니다:
1. BTIG 가상 생명공학 컨퍼런스: Ovid는 8월 6일 화요일 오전 10시(ET)에 파이어사이드 채팅에 참여할 예정입니다.
2. 2024 Wedbush PacGrow 헬스케어 컨퍼런스: 이 회사는 8월 13일 화요일 오전 10시 15분(ET)에 패널 토론에 참여합니다.
두 이벤트 모두 Ovid의 웹사이트인 investors.ovidrx.com의 이벤트 및 발표 섹션을 통해 실시간 웹캐스트로 접근할 수 있습니다. 생중계 후 아카이브된 재생도 회사 웹사이트에서 제공될 예정입니다.
Ovid Therapeutics Inc. (NASDAQ: OVID), une entreprise biopharmaceutique axée sur l'amélioration des vies des personnes affectées par des épilepsies et des conditions cérébrales, a annoncé sa participation à deux prochaines conférences pour investisseurs en août 2024 :
1. Conférence virtuelle de biotechnologie BTIG : Ovid participera à une discussion informelle le mardi 6 août à 10h00 ET.
2. Conférence de santé Wedbush PacGrow 2024 : L'entreprise participera à un panel de discussion le mardi 13 août à 10h15 ET.
Les deux événements seront accessibles via des webcasts en direct dans la section Événements & Présentations du site d'Ovid à investors.ovidrx.com. Des rediffusions seront disponibles sur le site de l'entreprise après les présentations en direct.
Ovid Therapeutics Inc. (NASDAQ: OVID), ein biopharmazeutisches Unternehmen, das sich auf die Verbesserung des Lebens von Menschen mit Epilepsie und Hirnerkrankungen konzentriert, hat seine Teilnahme an zwei bevorstehenden Investorenkonferenzen im August 2024 angekündigt:
1. BTIG Virtuelle Biotechnologiekonferenz: Ovid wird am Dienstag, den 6. August, um 10:00 Uhr ET an einem Fireside-Chat teilnehmen.
2. 2024 Wedbush PacGrow Gesundheitskonferenz: Das Unternehmen wird am Dienstag, den 13. August, um 10:15 Uhr ET an einer Podiumsdiskussion teilnehmen.
Beide Veranstaltungen werden über Live-Webcasts im Abschnitt Veranstaltungen & Präsentationen auf Ovids Website unter investors.ovidrx.com zugänglich sein. Aufzeichnungen sind nach den Live-Präsentationen auf der Unternehmenswebsite verfügbar.
- None.
- None.
NEW YORK, July 30, 2024 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company dedicated to meaningfully improving the lives of people affected by certain epilepsies and brain conditions, today announced that management will participate in two upcoming investor conferences in August:
- BTIG Virtual Biotechnology Conference – Ovid will participate in a fireside chat on Tuesday, August 6th at 10:00 a.m. ET.
- 2024 Wedbush PacGrow Healthcare Conference – Ovid will participate in a panel discussion on Tuesday, August 13th at 10:15 a.m. ET.
Live webcasts of the fireside chat and panel discussion can be accessed through the Events & Presentations section of the Company’s website at investors.ovidrx.com. An archived replay of the webcast will be available on the Company’s website following the live presentation.
About Ovid Therapeutics
Ovid Therapeutics Inc. is a New York-based biopharmaceutical company that is dedicated to improving the lives of people affected by certain epilepsies and brain conditions with seizure symptoms. The Company is advancing a pipeline of novel, targeted small molecule candidates that modulate the intrinsic and extrinsic factors involved in neuronal hyperexcitability causative of seizures and other neurological symptoms. Ovid is developing: OV888/GV101 capsule, a potent and highly selective ROCK2 inhibitor capsule, for the potential treatment of cerebral cavernous malformations and other rare central nervous system diseases; OV329, a GABA-aminotransferase inhibitor, a potential therapy for treatment-resistant seizures; and OV350, a direct activator of the KCC2 transporter, for the potential treatment of epilepsies and other psychiatric conditions. For more information about these and other Ovid research programs, please visit www.ovidrx.com.
Contacts
Investor Relations:
Garret Bonney
617-735-6093
IR@ovidrx.com
FAQ
When is Ovid Therapeutics participating in the BTIG Virtual Biotechnology Conference?
What investor conferences is Ovid Therapeutics (OVID) attending in August 2024?
How can investors access Ovid Therapeutics' presentations at the August 2024 conferences?
What type of event is Ovid Therapeutics participating in at the 2024 Wedbush PacGrow Healthcare Conference?
